Sanofi to buy Synthorx in $2.5bn deal
French biopharmaceutical company Sanofi has agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion. Sanofi said the deal would…
French biopharmaceutical company Sanofi has agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion. Sanofi said the deal would…
Chicago-based Cboe Global Markets said on Tuesday it would take full control of Amsterdam-based EuroCCP, Europe’s largest clearing house for stock trades. The move will…
The European Securities and Markets Authority (ESMA), the EU’s securities regulator, said it has published its second annual statistical report analysing the European Union’s (EU)…